Esophageal/Gastric Cancers Panel - Disclosures
|
Panel Member
|
Jaffer Ajani MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Bentrem MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sakti Chakrabarti MD |
|
Grant/Research Support
|
| Merck & Co., Inc. |
|
Product/Speakers Bureau
|
| Bristol Myers Squibb | SeaGen | Takeda Pharmaceuticals North America, Inc. |
|
Date Completed
|
04/16/2025 |
|
Panel Member
|
Carlos Corvera MD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Thomas D'Amico MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Prajnan Das MD, MPH, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peter Enzinger MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Thomas Enzler MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Hans Gerdes MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Gibson MD, PhD, FACP |
|
Grant/Research Support
|
| Papivax |
|
Date Completed
|
06/19/2024 |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Patrick Grierson MD, PhD |
|
Product/Speakers Bureau
|
| AstraZeneca Pharmaceuticals LP |
|
Royalty Income
|
| Aclaris Therapeutics |
|
Date Completed
|
05/13/2025 |
|
Panel Member
|
Garima Gupta MD |
|
Equity Interest/Stock Options
|
| Abbott Laboratories | Roche Laboratories, Inc. |
|
Date Completed
|
09/27/2024 |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Wayne Hofstetter MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Ilson MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Shadia Jalal MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sunnie Kim MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Samuel Klempner MD |
|
Grant/Research Support
|
| Arcus Biosciences | I-Mab |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Moshim Kukar MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jill Lacy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vincent Lam MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Byrne Lee MD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Frank Licciardi |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Shane Lloyd MD |
|
Grant/Research Support
|
| Naveris |
|
Date Completed
|
06/19/2024 |
|
Panel Member
|
Quan Ly MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Karen Matsukuma MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christine McLaughlin |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole McMillian MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ryan Merkow MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Miller MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mary Mulcahy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sharon Park PharmD, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kyle Perry MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jose Pimiento MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Deepti Reddi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Scott Reznik MD |
|
Equity Interest/Stock Options
|
| onconano |
|
Date Completed
|
06/19/2024 |
|
Panel Member
|
Robert Roses MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicholas Sansone MA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
MaryElizabeth Stein PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vivian Strong MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stacey Su MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Samantha Tamburro BSN, RN, CPON |
|
Salary
|
| Flatiron Health, Inc. |
|
Date Completed
|
10/24/2024 |
|
Panel Member
|
Nataliya Uboha MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zev Wainberg MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christopher Willett MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yanghee Woo MD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Harry Yoon MD |
|
Grant/Research Support
|
| Amgen Inc. | BeiGene | Bristol Myers Squibb | Carsgen | Merck & Co., Inc. |
|
Date Completed
|
07/30/2024 |
